The Oncology Institute, Inc.

TOI · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$17-$14-$20-$13
Dep. & Amort.$2$2$2$2
Deferred Tax$0-$0$0$0
Stock-Based Comp.$1$0$1$1
Change in WC-$6-$3$3$13
Other Non-Cash$7$5$8$2
Operating Cash Flow-$13-$10-$5$4
Investing Activities
PP&E Inv.-$1-$1-$0-$2
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1-$1-$0-$2
Financing Activities
Debt Repay.-$0-$0-$20-$0
Stock Issued$10$2$15$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1-$0-$0-$0
Financing Cash Flow$11$2-$5-$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$3-$9-$10$2
Supplemental Information
Beg. Cash$30$40$50$47
End Cash$28$30$40$50
Free Cash Flow-$13-$11-$5$2
The Oncology Institute, Inc. (TOI) Financial Statements & Key Stats | AlphaPilot